Gerresheimer AG (XTER:GXI) Cash And Cash Equivalents : €106 Mil (As of Feb. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Gerresheimer AG Cash And Cash Equivalents?

Gerresheimer AG's quarterly cash and cash equivalents increased from Aug. 2023 (€117.35 Mil) to Nov. 2023 (€122.34 Mil) but then stayed the same from Nov. 2023 (€122.34 Mil) to Feb. 2024 (€106.50 Mil).

Gerresheimer AG's annual cash and cash equivalents declined from Nov. 2021 (€114.05 Mil) to Nov. 2022 (€112.79 Mil) but then increased from Nov. 2022 (€112.79 Mil) to Nov. 2023 (€122.34 Mil).

Gerresheimer AG Cash And Cash Equivalents Historical Data

The historical data trend for Gerresheimer AG's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG Cash And Cash Equivalents Chart

Gerresheimer AG Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Cash And Cash Equivalents

Get a 7-Day Free Trial

85.83

87.95

114.05

112.79

122.34

Gerresheimer AG Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Cash And Cash Equivalents	Get a 7-Day Free Trial															104.78	117.01	117.35	122.34	106.50

Gerresheimer AG Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Gerresheimer AG (XTER:GXI) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Gerresheimer AG Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Gerresheimer AG (XTER:GXI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (XTER:GXI) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

GXId:UK 0NTI:UK GXI:Germany GXI:Germany GXI:Germany GXI:Austria

Address

Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468

Website

https://www.gerresheimer.com

Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.

Executives

Dietmar Siemssen	Board of Directors
Dr. Lukas Burkhardt	Board of Directors
Andrea Abt	Supervisory Board

Gerresheimer AG (XTER:GXI) Headlines

No Headlines